TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
作者:
主题词
AMP活化蛋白激酶类(AMP-Activated Protein Kinases);青少年(Adolescent);自噬(Autophagy);骨肿瘤(Bone Neoplasms);人类(Humans);次要组织相容性抗原(Minor Histocompatibility Antigens);NF-E2相关因子2(NF-E2-Related Factor 2);骨肉瘤(Osteosarcoma);活性氧(Reactive Oxygen Species);阻遏蛋白质类(Repressor Proteins);TOR丝氨酸-苏氨酸激酶(TOR Serine-Threonine Kinases)
DOI
10.1016/j.redox.2022.102344
PMID
35636015
发布时间
2022-07-16
- 浏览0
Redox biology
2022年53卷
102344页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文